These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7598859)

  • 1. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.
    Meredith SD; Levine PA; Burns JA; Gaffey MJ; Boyd JC; Weiss LM; Erickson NL; Williams ME
    Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):790-4. PubMed ID: 7598859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
    Williams ME; Gaffey MJ; Weiss LM; Wilczynski SP; Schuuring E; Levine PA
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1238-43. PubMed ID: 8217084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer.
    Alavi S; Namazie A; Calcaterra TC; Wang MB; Srivatsan ES
    Laryngoscope; 1999 Jun; 109(6):874-9. PubMed ID: 10369274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.
    Gaffey MJ; Iezzoni JC; Meredith SD; Boyd JC; Stoler MH; Weiss LM; Zukerberg LR; Levine PA; Arnold A; Williams ME
    Hum Pathol; 1995 Nov; 26(11):1221-6. PubMed ID: 7590696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome.
    Muller D; Millon R; Velten M; Bronner G; Jung G; Engelmann A; Flesch H; Eber M; Methlin G; Abecassis J
    Eur J Cancer; 1997 Nov; 33(13):2203-10. PubMed ID: 9470807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
    Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
    Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence.
    Fortin A; Guerry M; Guerry R; Talbot M; Parise O; Schwaab G; Bosq J; Bourhis J; Salvatori P; Janot F; Busson P
    Clin Cancer Res; 1997 Sep; 3(9):1609-14. PubMed ID: 9815850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck.
    Akervall JA; Jin Y; Wennerberg JP; Zätterström UK; Kjellén E; Mertens F; Willén R; Mandahl N; Heim S; Mitelman F
    Cancer; 1995 Sep; 76(5):853-9. PubMed ID: 8625189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
    Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
    Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization.
    Wang MB; Alavi S; Engstrom M; Lee J; Namazie A; Moatamed F; Srivatsan ES
    Anticancer Res; 1999; 19(2A):925-31. PubMed ID: 10368635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis.
    Noorlag R; van Kempen PM; Stegeman I; Koole R; van Es RJ; Willems SM
    Virchows Arch; 2015 Apr; 466(4):363-73. PubMed ID: 25663615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
    Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
    Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue.
    Fujii M; Ishiguro R; Yamashita T; Tashiro M
    Cancer Lett; 2001 Oct; 172(2):187-92. PubMed ID: 11566495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.
    Muller D; Millon R; Lidereau R; Engelmann A; Bronner G; Flesch H; Eber M; Methlin G; Abecassis J
    Eur J Cancer B Oral Oncol; 1994; 30B(2):113-20. PubMed ID: 8032300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.